Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: Bioequivalence Study of Patches With Different Equilibration Profiles [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study evaluating transdermal patches with different equilibration profiles for female contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Female Contraception | Phase 1 | Status: COMPLETED